Not Tagged
daiichi sankyo,astrazeneca
['$dsnky', '$azn']
discussant kohei shitara on some difficulties of her2 testing in a potential tumour-agnostic approach $azn $dsnky #asco23 
Once had a blue tick. Journalist at Evaluate Vantage. Interested in: oncology, immunology. Not interested in: what stock you bought today.